1 min read

Join Veristat to Discuss the Differences Between Nonclinical and Clinical Writing

veristat_candid-56_Opt640x225.png

 

Veristat will lead a roundtable discussion at the 2017 AMWA Medical Writing and Communication conference discussing how the writing process and content differs between nonclinical and clinical documents.


When?
Friday, November 3, 2017 from 12:15–1:45 PM Roundtable Lunch in the Exhibit Hall

 Title?

The Differences (and Similarities) Between Nonclinical and Clinical Writing

Roundtable Leader?

Christina Pligavko, Senior Medical Writer, Veristat, LLC, Southborough, MA

 


What You will Learn?

This proposed roundtable would be geared toward new medical writers who are interested in learning about nonclinical/technical writing or come from a background in nonclinical research. Nonclinical and clinical documents have their own specific purpose in drug development which goes beyond animal versus human. This roundtable will discuss how the writing process and content differs between nonclinical and clinical writing as well as the points of overlap. Topics for discussion would include (but are not limited to) the differences and similarities in: the guidances and regulations which oversee and define the content of each, the sources used in the generation of nonclinical versus clinical documents, and the challenges faced when given early development data in animals versus late stage human data.

 


Meet with Veristat:

To meet with Christina Pligavko at the event, please introduce yourself to her or schedule a meeting with her by filling out the form on the right hand side of this page.

To learn more about Veristat’s medical writing expertise, visit our Medical Writing page.

 

Get Our Latest Case Study :

"Achieving an Aggressive NDA Deadline Despite a 2 Month DB Lock Delay"

Imagine you are completing your regulatory submission project with only nine months left until submission day and you still have to migrate legacy data into SDTM format for 18 studies as well as 2 ongoing pivotal studies.    The outputs of which are required before the medical writing team can begin writing their integrated summaries.  Read how Veristat’s creativity saved the timeline despite a 2 Month DB Lock Delay.

 GET THE CASE STUDY

 

 

Share This Event:

   

1 min read

Chief Medical Officer Summit -CMO 360°

Meet the Veristat team at Booth #3, April 17th and 18th in Boston

The Science-First CRO™ and Consultancy Ready to...

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...